Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) Shares Outstanding (Diluted Average) (2020 - 2025)

Healthcare Triangle's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $61873.0 for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 17427.76% to $61873.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $61873.0, a 17427.76% increase, with the full-year FY2025 number at $61873.0, up 17427.76% from a year prior.
  • Shares Outstanding (Diluted Average) hit $61873.0 in Q4 2025 for Healthcare Triangle, down from $2.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for HCTI hit a ceiling of $36.0 million in Q3 2022 and a floor of $353.0 in Q4 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $13.2 million across 5 years, with a median of $4.2 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 99.99% in 2024 and later skyrocketed 17427.76% in 2025.
  • Tracing HCTI's Shares Outstanding (Diluted Average) over 5 years: stood at $29.4 million in 2021, then crashed by 87.43% to $3.7 million in 2022, then grew by 12.99% to $4.2 million in 2023, then plummeted by 99.99% to $353.0 in 2024, then skyrocketed by 17427.76% to $61873.0 in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for HCTI at $61873.0 in Q4 2025, $2.2 million in Q3 2025, and $2.3 million in Q2 2025.